Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: Evidence for the involvement of the dopaminergic system

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 204-211

  MacHado, D G ^a   Neis, V B ^a   Balen, G O ^a   Colla, A ^a   Cunha, M P ^a   Dalmarco, J B ^a   Pizzolatti, M G ^a   Prediger, R D ^a   Rodrigues, A L S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Dopaminergic system; Tail suspension test; Ursolic acid

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMFEBUTAMONE; APOMORPHINE; FLUOXETINE; IMIPRAMINE; SCH23390; SULPIRIDE; UNCLASSIFIED DRUG; URSOLIC ACID;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EXPLORATORY BEHAVIOR; IMMOBILIZATION; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REARING; ROSEMARY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DOPAMINE; MALE; MICE; ROSMARINUS; SWIMMING; TRITERPENES;

MUS; ROSMARINUS OFFICINALIS;

EID: 84866290783     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.08.016     Document Type: Article

References (64)

1. S. Akhondzadeh, and J. Maleki Herbal medicines in the treatment of psychiatric and neurological disorders Iran J Psychiatry 1 2006 1 11
2. F. Bai, X. Li, M. Clay, T. Lindstrom, and P. Skolnick Intra- and interstrain differences in models of 'behavioral despair' Pharmacol Biochem Behav 70 2001 187 192
3. D. Baricevic, S. Sosa, R. Della Loggia, A. Tubaro, B. Simonovska, and A. Krasna Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid J Ethnopharmacol 75 2001 125 132
4. P. Baumann Pharmacotherapy of depression: recent developments Rev Med Suisse 3 2007 2079 2080
5. J.P. Benincá, J.B. Dalmarco, M.G. Pizzolatti, and T.S. Fröde Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice Food Chem 124 2011 468 475
6. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat Rev Neurosci 7 2006 137 141
7. A.R. Bilia, S. Gallori, and F.F. Vincieri St. John's Wort and depression. Efficacy, safety and tolerability - an update Life Sci 70 2002 3077 3096
8. R.W. Binfaré, A.O. Rosa, K.R. Lobato, A.R.S. Santos, and A.L.S. Rodrigues Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission Prog Neuropsychopharmacol Biol Psychiatry 33 2009 530 540
9. R.W. Binfaré, M. Mantovani, J. Budni, A.R.S. Santos, and A.L.S. Rodrigues Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test Eur J Pharmacol 638 2010 78 83
10. M. Bourin, F. Chenu, N. Ripoll, and D.J.P. David A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests Behav Brain Res 164 2005 266 269
11. N. Brunello, J. Mendlewicz, S. Kasper, B. Leonard, S. Montgomery, and J. Nelson The role of noradrenaline and selective noradrenaline reuptake inhibition in depression Eur Neuropsychopharmacol 12 2002 461 475
12. J.C. Capra, M.P. Cunha, D.G. Machado, A.D.E. Zomkowski, B.G. Mendes, and A.R.S. Santos Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems Eur J Pharmacol 643 2010 232 238
13. R.N. Clark, C.R. Ashby Jr., P.V. Ramachandran, and R.E. Strecker Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat Synapse 23 1996 125 131
14. B.R. Cooper, C.M. Wang, R.F. Cox, R. Norton, V. Shea, and R.M. Ferris Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism Neuropsychopharmacology 11 1994 133 141
15. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci Biobehav Rev 29 2005 571 625
16. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1913 1920
17. Cunha MP, Machado DG, Capra JC, Jacinto J, Bettio LE, Rodrigues ALS. Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol in press. http://dx.doi.org/10.1177/0269881112447989.
18. P.S. D'Aquila, M. Collu, L. Pani, G.L. Gessa, and G. Serra Antidepressant-like effect of selective D1 receptor agonist in the behavioural despair animal model of depression Eur J Pharmacol 262 1994 107 111
19. P.S. D'Aquila, M. Collu, G.L. Gessa, and G. Serra The role of dopamine in the mechanism of action of antidepressants drugs Eur J Pharmacol 405 2000 365 373
20. S. Dhillon, L.P. Yang, and M.P. Curran Bupropion: a review of its use in the management of major depressive disorder Drugs 68 2008 653 689
21. B.W. Dunlop, and C.B. Nemeroff The role of dopamine in the pathophysiology of depression Arch Gen Psychiatry 64 2007 327 337
22. K.P. Ebmeier, C. Donaghey, and J.D. Steele Recent developments and current controversies in depression Lancet 367 2006 153 167
23. D.L. Evans, D.S. Charney, L. Lewis, R.N. Golden, J.M. Gorman, and K.R. Krishnan Mood disorders in the medically ill: scientific review and recommendations Biol Psychiatry 58 2005 175 189
24. F.C.B. Felipe, J.T.S. Filho, L.E.O. Souza, J.A. Silveira, D.E.A. Uchoa, and E.R. Silveira Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in mice Phytomedicine 14 2007 605 612
25. A.E. Freitas, J. Budni, K.R. Lobato, R.W. Binfaré, D.G. Machado, and J. Jacinto Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 34 2010 335 343
26. A. Gobert, J.M. Rivet, L. Cistarelli, and M.J. Millan Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats J Neurochem 68 1997 1326 1329
27. S. Hirano, S. Miyata, K. Onodera, and J. Kamei Involvement of dopamine D1 receptors and α1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test Eur J Pharmacol 562 2007 72 76
28. Y. Ikeda, A. Murakami, and H. Ohigashi Ursolic Acid: an anti- and pro-inflammatory triterpenoid Mol Nutr Food Res 25 2008 26 42
29. S.M. Jang, S.T. Yee, J. Choi, M.S. Choi, G.M. Do, and S.M. Jeon Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet Int Immunopharmacol 9 2009 113 119
30. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test Brain Res Bull 67 2005 53 61
31. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
32. J. Liu Pharmacology of oleanolic acid and ursolic acid J Ethnopharmacol 49 1995 57 68
33. J. Lu, Y.L. Zheng, D.M. Wu, L. Luo, D.X. Sun, and Q. Shan Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose Biochem Pharmacol 74 2007 1078 1090
34. S. MacGillivray, B. Arroll, S. Hatcher, S. Ogston, I. Reid, and F. Sullivan Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis BMJ 326 2003 1014
35. D.G. Machado, M.P. Kaster, R.W. Binfaré, M. Dias, A.R. Santos, and M.G. Pizzolatti Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 31 2007 421 428
36. D.G. Machado, L.E. Bettio, M.P. Cunha, A.R. Santos, M.G. Pizzolatti, and I.M. Brighente Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems Eur J Pharmacol 587 2008 163 168
37. D.G. Machado, L.E.B. Bettio, M.P. Cunha, J.C. Capra, J.B. Dalmarco, and M.G. Pizzolatti Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 33 2009 642 650
38. S.B. Mahato, and A. Kundu 13C NMR spectra of pentacyclic triterpenoids - a compilation and some salient features Phytochemistry 37 1994 1517 1575
39. A. Mancinelli, V. D'Aranno, M.A. Stasi, A. Lecci, F. Borsini, and A. Meli Effects of enantiomers of propranolol on desipramine-induced anti-immobility in the forced swimming test in the rat Pharmacol Res 23 1991 47 50
40. M.J. Millan, L. Maiofiss, D. Cussac, V. Audinot, J.A. Boutin, and A. Newman-Tancredi Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J Pharmacol Exp Ther 303 2002 791 804
41. C. Mombereau, K. Kaupmann, W. Froestl, G. Sansig, H. van der Putten, and J.F. Cryan Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior Neuropsychopharmacology 29 2004 1050 1062
42. O.V. Mortensen, and S.G. Amara Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters J Neurochem 98 2006 1531 1540
43. G.I. Papakostas Dopaminergic-based pharmacotherapies for depression Eur Neuropsychopharmacol 16 2006 391 402
44. S. Pemminati, H.N. Gopalakrishna, V.K. Ashok, C. Maitrayee, V. Bheemesh, and G. Chetan Effect of chronic administration of ursolic acid on haloperidol induced catalepsy in albino mice Drug Invent Today 3 2011 83 85
45. W.H. Peng, K.L. Lo, Y.H. Lee, T.H. Hung, and Y.C. Lin Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice Life Sci 81 2007 933 938
46. W. Pitchot, G. Scantamburlo, E. Pinto, and M. Ansseau Recovering from depression: a matter of objective and determination Rev Med Liege 65 2010 370 380
47. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
48. J.J. Rakofsky, P.E. Holtzheimer, and C.B. Nemeroff Emerging targets for antidepressant therapies Curr Opin Chem Biol 13 2009 291 302
49. C.E. Renard, A.J. Fiocco, F. Clenet, M. Hascoet, and M. Bourin Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology (Berl) 159 2001 42 50
50. E. Richelson Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance J Clin Psychiatry 64 2003 5 12
51. A.L.S. Rodrigues, J.B.T. Rocha, C.F. Mello, and D.O. Souza Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks Pharmacol Toxicol 79 1996 150 156
52. A.L.S. Rodrigues, G.L. da Silva, A.S. Mateussi, E.S. Fernandes, O.G. Miguel, and R.A. Yunes Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus Life Sci 70 2002 1347 1358
53. Z. Rogóz, and K. Gołembiowska Effect of metyrapone on the fluoxetine-induced change in extracellular dopamine, serotonin and their metabolites in the rat frontal cortex Pharmacol Rep 62 2010 1015 1022
54. C. Sanchez, and J. Hyttel Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding Cell Mol Neurobiol 19 1999 467 489
55. Y.H. Shih, Y.C. Chein, J.Y. Wang, and Y.S. Fu Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats Neurosci Lett 362 2004 136 140
56. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
57. S. Tsai, and M.C. Yin Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 Cells J Food Sci 73 2008 174 178
58. W. Wang, X. Hu, Z. Zhao, P. Liu, Y. Hu, and J. Zhou Antidepressant-like effects of liquiritin and isoliquiritin from Glycyrrhiza uralensis in the forced swimming test and tail suspension test in mice Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1179 1184
59. E. Whiskey, U. Werneke, and D. Taylor A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical Int Clin Psychopharmacol 16 2001 239 252
60. M. Wong, and J. Licinio Research and treatment approaches to depression Nat Rev Neurosci 2 2001 343 351
61. J. Yamada, Y. Sugimoto, and S. Yamada Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test Eur J Pharmacol 504 2004 207 211
62. Y. Yan-xia, G. Zhen-lun, Y. Jiang-lin, C. Wen-hsien, K. Chi-yi, and Q. Zheng-hong Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway Chin Med J 123 2010 1915 1923
63. L.T. Yi, H.L. Xu, J. Feng, X. Zhan, L.P. Zhou, and C.C. Cui Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin Physiol Behav 102 2011 1 6
64. Z. Zhang Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders Life Sci 75 2004 1659 1699